Medical Care
Global Chronic Idiopathic Constipation Treatment Market Research Report 2025
- Jul 08, 25
- ID: 348445
- Pages: 78
- Figures: 71
- Views: 10
The global market for Chronic Idiopathic Constipation Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage of anti-inflammatory agents, and drastic decline in the intake of dietary fibers. Over the past few years, considerable efforts have been made to improve the management of chronic idiopathic constipation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Idiopathic Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Idiopathic Constipation Treatment.
The Chronic Idiopathic Constipation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Idiopathic Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Idiopathic Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Allergan
Bausch Health
Sanofi
Takeda Pharmaceutical Company
SEBELA PHARMACEUTICALS
Ironwood Pharmaceuticals, Inc.
Albireo Pharma, Inc.
Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
Segment by Type
Blood Tests
Sigmoidoscopy
Colonoscopy
Balloon Expulsion Test
Anorectal Manometry
Colonic Transit Study
Defecography
Others
Segment by Application
Hospitals
Gastroenterology clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Idiopathic Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage of anti-inflammatory agents, and drastic decline in the intake of dietary fibers. Over the past few years, considerable efforts have been made to improve the management of chronic idiopathic constipation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Idiopathic Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Idiopathic Constipation Treatment.
The Chronic Idiopathic Constipation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Idiopathic Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Idiopathic Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Allergan
Bausch Health
Sanofi
Takeda Pharmaceutical Company
SEBELA PHARMACEUTICALS
Ironwood Pharmaceuticals, Inc.
Albireo Pharma, Inc.
Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
Segment by Type
Blood Tests
Sigmoidoscopy
Colonoscopy
Balloon Expulsion Test
Anorectal Manometry
Colonic Transit Study
Defecography
Others
Segment by Application
Hospitals
Gastroenterology clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Idiopathic Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Tests
1.2.3 Sigmoidoscopy
1.2.4 Colonoscopy
1.2.5 Balloon Expulsion Test
1.2.6 Anorectal Manometry
1.2.7 Colonic Transit Study
1.2.8 Defecography
1.2.9 Others
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Constipation Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Gastroenterology clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Idiopathic Constipation Treatment Market Perspective (2020-2031)
2.2 Global Chronic Idiopathic Constipation Treatment Growth Trends by Region
2.2.1 Global Chronic Idiopathic Constipation Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Idiopathic Constipation Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Idiopathic Constipation Treatment Market Dynamics
2.3.1 Chronic Idiopathic Constipation Treatment Industry Trends
2.3.2 Chronic Idiopathic Constipation Treatment Market Drivers
2.3.3 Chronic Idiopathic Constipation Treatment Market Challenges
2.3.4 Chronic Idiopathic Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue
3.1.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Idiopathic Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Idiopathic Constipation Treatment Revenue
3.4 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Treatment Revenue in 2024
3.5 Global Key Players of Chronic Idiopathic Constipation Treatment Head office and Area Served
3.6 Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application
3.7 Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Idiopathic Constipation Treatment Breakdown Data by Type
4.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Idiopathic Constipation Treatment Breakdown Data by Application
5.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
6.2 North America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
7.2 Europe Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
9.2 Latin America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Chronic Idiopathic Constipation Treatment Introduction
11.1.4 Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Chronic Idiopathic Constipation Treatment Introduction
11.2.4 Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Chronic Idiopathic Constipation Treatment Introduction
11.3.4 Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.3.5 Bausch Health Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Chronic Idiopathic Constipation Treatment Introduction
11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Takeda Pharmaceutical Company
11.5.1 Takeda Pharmaceutical Company Company Details
11.5.2 Takeda Pharmaceutical Company Business Overview
11.5.3 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Introduction
11.5.4 Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.5.5 Takeda Pharmaceutical Company Recent Development
11.6 SEBELA PHARMACEUTICALS
11.6.1 SEBELA PHARMACEUTICALS Company Details
11.6.2 SEBELA PHARMACEUTICALS Business Overview
11.6.3 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Introduction
11.6.4 SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.6.5 SEBELA PHARMACEUTICALS Recent Development
11.7 Ironwood Pharmaceuticals, Inc.
11.7.1 Ironwood Pharmaceuticals, Inc. Company Details
11.7.2 Ironwood Pharmaceuticals, Inc. Business Overview
11.7.3 Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.7.4 Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.7.5 Ironwood Pharmaceuticals, Inc. Recent Development
11.8 Albireo Pharma, Inc.
11.8.1 Albireo Pharma, Inc. Company Details
11.8.2 Albireo Pharma, Inc. Business Overview
11.8.3 Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.8.4 Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.8.5 Albireo Pharma, Inc. Recent Development
11.9 Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
11.9.1 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
11.9.2 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
11.9.3 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Introduction
11.9.4 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.9.5 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
11.10 Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
11.10.1 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
11.10.2 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
11.10.3 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Introduction
11.10.4 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.10.5 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Tests
1.2.3 Sigmoidoscopy
1.2.4 Colonoscopy
1.2.5 Balloon Expulsion Test
1.2.6 Anorectal Manometry
1.2.7 Colonic Transit Study
1.2.8 Defecography
1.2.9 Others
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Constipation Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Gastroenterology clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Idiopathic Constipation Treatment Market Perspective (2020-2031)
2.2 Global Chronic Idiopathic Constipation Treatment Growth Trends by Region
2.2.1 Global Chronic Idiopathic Constipation Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Idiopathic Constipation Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Idiopathic Constipation Treatment Market Dynamics
2.3.1 Chronic Idiopathic Constipation Treatment Industry Trends
2.3.2 Chronic Idiopathic Constipation Treatment Market Drivers
2.3.3 Chronic Idiopathic Constipation Treatment Market Challenges
2.3.4 Chronic Idiopathic Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue
3.1.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Idiopathic Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Idiopathic Constipation Treatment Revenue
3.4 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Treatment Revenue in 2024
3.5 Global Key Players of Chronic Idiopathic Constipation Treatment Head office and Area Served
3.6 Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application
3.7 Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Idiopathic Constipation Treatment Breakdown Data by Type
4.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Idiopathic Constipation Treatment Breakdown Data by Application
5.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
6.2 North America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
7.2 Europe Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
9.2 Latin America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Chronic Idiopathic Constipation Treatment Introduction
11.1.4 Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Chronic Idiopathic Constipation Treatment Introduction
11.2.4 Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Chronic Idiopathic Constipation Treatment Introduction
11.3.4 Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.3.5 Bausch Health Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Chronic Idiopathic Constipation Treatment Introduction
11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Takeda Pharmaceutical Company
11.5.1 Takeda Pharmaceutical Company Company Details
11.5.2 Takeda Pharmaceutical Company Business Overview
11.5.3 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Introduction
11.5.4 Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.5.5 Takeda Pharmaceutical Company Recent Development
11.6 SEBELA PHARMACEUTICALS
11.6.1 SEBELA PHARMACEUTICALS Company Details
11.6.2 SEBELA PHARMACEUTICALS Business Overview
11.6.3 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Introduction
11.6.4 SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.6.5 SEBELA PHARMACEUTICALS Recent Development
11.7 Ironwood Pharmaceuticals, Inc.
11.7.1 Ironwood Pharmaceuticals, Inc. Company Details
11.7.2 Ironwood Pharmaceuticals, Inc. Business Overview
11.7.3 Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.7.4 Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.7.5 Ironwood Pharmaceuticals, Inc. Recent Development
11.8 Albireo Pharma, Inc.
11.8.1 Albireo Pharma, Inc. Company Details
11.8.2 Albireo Pharma, Inc. Business Overview
11.8.3 Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.8.4 Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.8.5 Albireo Pharma, Inc. Recent Development
11.9 Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
11.9.1 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
11.9.2 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
11.9.3 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Introduction
11.9.4 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.9.5 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
11.10 Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
11.10.1 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
11.10.2 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
11.10.3 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Introduction
11.10.4 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)
11.10.5 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Tests
Table 3. Key Players of Sigmoidoscopy
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Balloon Expulsion Test
Table 6. Key Players of Anorectal Manometry
Table 7. Key Players of Colonic Transit Study
Table 8. Key Players of Defecography
Table 9. Global Chronic Idiopathic Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Chronic Idiopathic Constipation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2025)
Table 13. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2026-2031)
Table 15. Chronic Idiopathic Constipation Treatment Market Trends
Table 16. Chronic Idiopathic Constipation Treatment Market Drivers
Table 17. Chronic Idiopathic Constipation Treatment Market Challenges
Table 18. Chronic Idiopathic Constipation Treatment Market Restraints
Table 19. Global Chronic Idiopathic Constipation Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Chronic Idiopathic Constipation Treatment Market Share by Players (2020-2025)
Table 21. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)
Table 22. Ranking of Global Top Chronic Idiopathic Constipation Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Chronic Idiopathic Constipation Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Chronic Idiopathic Constipation Treatment, Headquarters and Area Served
Table 25. Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application
Table 26. Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Idiopathic Constipation Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. Bayer AG Company Details
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Chronic Idiopathic Constipation Treatment Product
Table 54. Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Allergan Company Details
Table 57. Allergan Business Overview
Table 58. Allergan Chronic Idiopathic Constipation Treatment Product
Table 59. Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. Bausch Health Company Details
Table 62. Bausch Health Business Overview
Table 63. Bausch Health Chronic Idiopathic Constipation Treatment Product
Table 64. Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 65. Bausch Health Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Chronic Idiopathic Constipation Treatment Product
Table 69. Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Takeda Pharmaceutical Company Company Details
Table 72. Takeda Pharmaceutical Company Business Overview
Table 73. Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product
Table 74. Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 75. Takeda Pharmaceutical Company Recent Development
Table 76. SEBELA PHARMACEUTICALS Company Details
Table 77. SEBELA PHARMACEUTICALS Business Overview
Table 78. SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product
Table 79. SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 80. SEBELA PHARMACEUTICALS Recent Development
Table 81. Ironwood Pharmaceuticals, Inc. Company Details
Table 82. Ironwood Pharmaceuticals, Inc. Business Overview
Table 83. Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Product
Table 84. Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 85. Ironwood Pharmaceuticals, Inc. Recent Development
Table 86. Albireo Pharma, Inc. Company Details
Table 87. Albireo Pharma, Inc. Business Overview
Table 88. Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Product
Table 89. Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 90. Albireo Pharma, Inc. Recent Development
Table 91. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
Table 92. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
Table 93. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product
Table 94. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 95. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
Table 96. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
Table 97. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
Table 98. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product
Table 99. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 100. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Chronic Idiopathic Constipation Treatment Picture
Figure 2. Global Chronic Idiopathic Constipation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Idiopathic Constipation Treatment Market Share by Type: 2024 VS 2031
Figure 4. Blood Tests Features
Figure 5. Sigmoidoscopy Features
Figure 6. Colonoscopy Features
Figure 7. Balloon Expulsion Test Features
Figure 8. Anorectal Manometry Features
Figure 9. Colonic Transit Study Features
Figure 10. Defecography Features
Figure 11. Others Features
Figure 12. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Chronic Idiopathic Constipation Treatment Market Share by Application: 2024 VS 2031
Figure 14. Hospitals Case Studies
Figure 15. Gastroenterology clinics Case Studies
Figure 16. Diagnostic Centers Case Studies
Figure 17. Others Case Studies
Figure 18. Chronic Idiopathic Constipation Treatment Report Years Considered
Figure 19. Global Chronic Idiopathic Constipation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Chronic Idiopathic Constipation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Chronic Idiopathic Constipation Treatment Market Share by Region: 2024 VS 2031
Figure 22. Global Chronic Idiopathic Constipation Treatment Market Share by Players in 2024
Figure 23. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Treatment Revenue in 2024
Figure 25. North America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 27. United States Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 31. Germany Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2031)
Figure 39. China Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 47. Mexico Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 51. Turkey Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 55. Allergan Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 56. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 59. SEBELA PHARMACEUTICALS Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 60. Ironwood Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 61. Albireo Pharma, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 62. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 63. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Tests
Table 3. Key Players of Sigmoidoscopy
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Balloon Expulsion Test
Table 6. Key Players of Anorectal Manometry
Table 7. Key Players of Colonic Transit Study
Table 8. Key Players of Defecography
Table 9. Global Chronic Idiopathic Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Chronic Idiopathic Constipation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2025)
Table 13. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2026-2031)
Table 15. Chronic Idiopathic Constipation Treatment Market Trends
Table 16. Chronic Idiopathic Constipation Treatment Market Drivers
Table 17. Chronic Idiopathic Constipation Treatment Market Challenges
Table 18. Chronic Idiopathic Constipation Treatment Market Restraints
Table 19. Global Chronic Idiopathic Constipation Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Chronic Idiopathic Constipation Treatment Market Share by Players (2020-2025)
Table 21. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)
Table 22. Ranking of Global Top Chronic Idiopathic Constipation Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Chronic Idiopathic Constipation Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Chronic Idiopathic Constipation Treatment, Headquarters and Area Served
Table 25. Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application
Table 26. Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Idiopathic Constipation Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. Bayer AG Company Details
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Chronic Idiopathic Constipation Treatment Product
Table 54. Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Allergan Company Details
Table 57. Allergan Business Overview
Table 58. Allergan Chronic Idiopathic Constipation Treatment Product
Table 59. Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. Bausch Health Company Details
Table 62. Bausch Health Business Overview
Table 63. Bausch Health Chronic Idiopathic Constipation Treatment Product
Table 64. Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 65. Bausch Health Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Chronic Idiopathic Constipation Treatment Product
Table 69. Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Takeda Pharmaceutical Company Company Details
Table 72. Takeda Pharmaceutical Company Business Overview
Table 73. Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product
Table 74. Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 75. Takeda Pharmaceutical Company Recent Development
Table 76. SEBELA PHARMACEUTICALS Company Details
Table 77. SEBELA PHARMACEUTICALS Business Overview
Table 78. SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product
Table 79. SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 80. SEBELA PHARMACEUTICALS Recent Development
Table 81. Ironwood Pharmaceuticals, Inc. Company Details
Table 82. Ironwood Pharmaceuticals, Inc. Business Overview
Table 83. Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Product
Table 84. Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 85. Ironwood Pharmaceuticals, Inc. Recent Development
Table 86. Albireo Pharma, Inc. Company Details
Table 87. Albireo Pharma, Inc. Business Overview
Table 88. Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Product
Table 89. Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 90. Albireo Pharma, Inc. Recent Development
Table 91. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
Table 92. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
Table 93. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product
Table 94. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 95. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
Table 96. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
Table 97. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
Table 98. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product
Table 99. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)
Table 100. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Chronic Idiopathic Constipation Treatment Picture
Figure 2. Global Chronic Idiopathic Constipation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Idiopathic Constipation Treatment Market Share by Type: 2024 VS 2031
Figure 4. Blood Tests Features
Figure 5. Sigmoidoscopy Features
Figure 6. Colonoscopy Features
Figure 7. Balloon Expulsion Test Features
Figure 8. Anorectal Manometry Features
Figure 9. Colonic Transit Study Features
Figure 10. Defecography Features
Figure 11. Others Features
Figure 12. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Chronic Idiopathic Constipation Treatment Market Share by Application: 2024 VS 2031
Figure 14. Hospitals Case Studies
Figure 15. Gastroenterology clinics Case Studies
Figure 16. Diagnostic Centers Case Studies
Figure 17. Others Case Studies
Figure 18. Chronic Idiopathic Constipation Treatment Report Years Considered
Figure 19. Global Chronic Idiopathic Constipation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Chronic Idiopathic Constipation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Chronic Idiopathic Constipation Treatment Market Share by Region: 2024 VS 2031
Figure 22. Global Chronic Idiopathic Constipation Treatment Market Share by Players in 2024
Figure 23. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Treatment Revenue in 2024
Figure 25. North America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 27. United States Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 31. Germany Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2031)
Figure 39. China Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 47. Mexico Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)
Figure 51. Turkey Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 55. Allergan Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 56. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 59. SEBELA PHARMACEUTICALS Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 60. Ironwood Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 61. Albireo Pharma, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 62. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 63. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232